Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Bullboard Posts
Comment by Cryptobreakon Apr 01, 2020 2:37pm
57 Views
Post# 30869371

RE:Hows it Going Now for Keeping Up with Debt Payments?

RE:Hows it Going Now for Keeping Up with Debt Payments?WTF man... Are you that desperate? Running out of material to bash on? Did you even read whst you just posted.. Clearly a non issue..
Bradwait wrote: Noticed this on sedar posted on last reported financials.

[a] Note payable to HDL   
 
On May 4, 2016, StageZero Life Sciences Holding (formal GeneNews (USA), Inc.) received a notice of default from HDL for missing two monthly payments under the terms of the Notes that were renegotiated in March 2016. On August 15, 2016, Richard Arrowsmith, as Liquidating Trustee of the HDL Liquidating Trust (the “Liquidating Trust”), filed a Complaint against StageZero Life Sciences Holding (formal GeneNews (USA), Inc.), in the United States Bankruptcy Court, Eastern District of Virginia, Richmond Division (the “Bankruptcy Court”). The parties entered into negotiations and on March 1, 2017 reached a settlement agreement pursuant to which StageZero Life Sciences Holding (formal GeneNews (USA), Inc.) would pay the Liquidating Trust an aggregate settlement amount of $2,095,843, to be paid in a $25,000 upfront payment and monthly payments of $15,000 beginning March 1, 2017 to July 1, 2017, followed by monthly payments of $10,000 until the outstanding debt has been paid in full.  The Bankruptcy Court granted the Liquidating Trust’s motion to approve the settlement agreement and, on April 27, 2017, the action against StageZero Life Sciences Holding (formal GeneNews (USA), Inc.) was dismissed with prejudice by the Bankruptcy Court. During nine months 2019, StageZero Life Sciences Holding (formal GeneNews (USA), Inc.). paid $90,000 [2018 - $110,000]. The change in fair value associated with the renegotiation resulted in a reduction in the fair value of the debt by $1,183,571.


Bullboard Posts